Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients

Eur Heart J Cardiovasc Pharmacother. 2021 Jan 16;7(1):76-77. doi: 10.1093/ehjcvp/pvaa083.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • COVID-19 / mortality*
  • Critical Illness
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Prospective Studies
  • SARS-CoV-2*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors

Associated data

  • ClinicalTrials.gov/NCT04321265